LA
ALNY icon

LBP AM’s Alnylam Pharmaceuticals ALNY Stock Holding History

LBP AM’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Hold
14,206
– – 0.04% 254
2026
Q1 		$4.7M Buy
14,206
+6,416
+82% +$2.18M 0.06% 213
2025
Q4 		$3.1M Sell
7,790
-394
-5% -$174K 0.04% 273
2025
Q3 		$3.73M Sell
8,184
-138
-2% -$56.2K 0.05% 243
2025
Q2 		$2.71M Buy
+8,322
New +$2.3M 0.04% 254
2023
Q2 		– Sell
-2,536
Closed -$508K – 416
2023
Q1 		$508K Sell
2,536
-178
-7% -$37.4K 0.01% 422
2022
Q4 		$645K Buy
+2,714
New +$579K 0.02% 397

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LBP AM's ALNY Position: Q2 2026 in Review

LBP AM held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 14,206 shares worth $4.28M. The position accounts for 0.04% of the portfolio, ranked #254.

LBP AM first reported a position in ALNY in Q4 2022 and has held it in 7 quarters since. The position peaked at $4.7M in Q1 2026. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • LBP AM held 14,206 shares of Alnylam Pharmaceuticals worth $4.28M as of Q2 2026.
  • LBP AM left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.04% of LBP AM's portfolio in Q2 2026, its #254 holding.
  • LBP AM first reported a position in Alnylam Pharmaceuticals in Q4 2022 and has held it in 7 quarters since.
  • LBP AM's Alnylam Pharmaceuticals position peaked at $4.7M in Q1 2026.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.